The Patent Finder

2,4,5-Trisubstituted 1,2,4-Triazolones Useful as Inhibitors of Dhodh

Bayer Pharma Aktiengesellschaft

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/EP2017/077252, filed Oct 25, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,815,2152,4,5-Trisubstituted 1,2,4-Triazolones Useful as Inhibitors of Dhodh
In force
 · High confidence
UsedRemaining
Bayer Aktiengesellschaft and Bayer Pharma AktiengesellschaftIn forceHigh confidence
US 11,130,7452,4,5-Trisubstituted 1,2,4-Triazolones Useful as Inhibitors of Dhodh
In force
 · Low confidence
Bayer Aktiengesellschaft and Bayer Pharma AktiengesellschaftIn forceLow confidence
US 11,713,3042,4,5-Trisubstituted 1,2,4-Triazolones Useful as Inhibitors of Dhodh
In force
 · Medium confidence
Bayer Aktiengesellschaft and Bayer Pharma AktiengesellschaftIn forceMedium confidence
US 12,486,2482,4,5-Trisubstituted 1,2,4-Triazolones Useful as Inhibitors of Dhodh
In force
 · Medium confidence
Bayer Pharma Aktiengesellschaft and Bayer AktiengesellschaftIn forceMedium confidence
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited